In addition to the core markers of AD— Aβ, tau proteins, and microglial responses—it is evident that the vascular system, BBB, brain clearance system, peripheral immune system, and potentially gut microbes also affect the clinical progression of the disease [84, 85]. This evidence concerns the gene MAPT and Alzheimer disease.